Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 25 min ago
PreprintAll rights reservedbioRxiv

RNA evidence supports clinical stage antibody drug targets in oncology

  • D. Pozzobon
  • N. Khusial
  • R. Spreafico
  • A. Csala1
  1. 1Genmab
Read full textPDFDOICite

Related

  1. Antibody-Drug Conjugates in Solid Tumor Oncology and the Frontier of Precision Immunosuppression: A Mechanistic, Translational, and Clinical Review
    Ibraheem Masoud, Nada Saed Homod Al Shaer, Ahmad Masoud +8
    International Journal of Molecular SciencesPeer-reviewedCC BY5 citedImmunologyOpenAlex
  2. Antibody-drug conjugates in precision oncology
    Barbara Pistilli, Raffaele Colombo, Maria Fernanda Mosele +1
    Cancer CellPeer-reviewedCC BY12 citedImmunologyMedical imaging & radiologyOpenAlex
  3. Optimal Maturation Protocols for High-Affinity Antibody Targets: A Path-Integral Approach
    Marian Huot, Marco Molari, Rémi Monasson +1
    PRX LifePeer-reviewedCC BY 4.0Full textGenetics & genomicsHAL
  4. A fibril-selective single-domain antibody targets pathogenic amyloid-β assemblies and protects human neurons
    Matt A. Greenlee, Soukaina Amniouel, Isabel Rivera +8
    iSciencePeer-reviewedCC BY 4.0Full textCell biologyNeuroscienceCell PressCrossrefEurope PMCEurope PMC+1
  5. IgG coating of Lactobacillus crispatus is associated with cervicovaginal immune homeostasis and reduced preterm birth rates, identifying S-layer proteins as candidate antibody targets
    Belen Gimeno-Molina, Alexiane Decout, Ryan L. Love +15
    MicrobiomePeer-reviewedCC BY 4.0MicrobiologyCrossref

Cite

BibTeXRIS
BibTeX
@misc{pozzobon2026evidence,
  title = {{RNA evidence supports clinical stage antibody drug targets in oncology}},
  author = {D. Pozzobon and N. Khusial and R. Spreafico and A. Csala},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.06.757024},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.06.757024v1},
}
RIS
TY  - UNPB
TI  - RNA evidence supports clinical stage antibody drug targets in oncology
AU  - D. Pozzobon
AU  - N. Khusial
AU  - R. Spreafico
AU  - A. Csala
PY  - 2026
DA  - 2026/10/06
PB  - bioRxiv
DO  - 10.64898/2026.10.06.757024
UR  - https://www.biorxiv.org/content/10.64898/2026.10.06.757024v1
ER  -